Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glucagonoma, Insulinoma, Melanoma, Pheochromocytoma, Somatostatinoma, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Islet Cell, Carcinoma, Medullary

NCT02890069 2023-01-11

A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

Phase 1 Completed

298 enrolled

BreastGastrointestinalGenitourinaryThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02071862 2022-07-20

Study of the Glutaminase Inhibitor CB-839 in Solid Tumors

Phase 1 Completed

210 enrolled

BreastGenitourinaryOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Mesothelioma, Triple Negative Breast Neoplasms

NCT01152801 2020-12-21

Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

Phase 1 Completed

64 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT01482156 2020-12-21

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Phase 1 Completed

46 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell

NCT02077933 2020-12-08

Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advanced Breast Cancer Patients, Renal Cell Cancer and Pancreatic Tumors

Phase 1 Completed

79 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasms

NCT02454478 2019-03-19

Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

Phase 1 Completed

7 enrolled 17 charts

Genitourinary

Carcinoma, Carcinoma, Renal Cell

NCT01115803 2019-02-05

A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

Phase 1 Terminated

29 enrolled 19 charts

EndocrineGenitourinaryNETThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT00303732 2016-03-03

PTK/RAD

Phase 1 Completed

37 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT01334073 2015-07-23

EVAX

Phase 1 Completed

19 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00788060 2015-02-16

Rad/Sutent

Phase 1 Completed

5 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00384969 2014-08-18

Sorafenib and RAD001 Renal Cell Carcinoma

Phase 1 Completed

21 enrolled

Genitourinary

Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01677390 2014-01-28

A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma

Phase 1 Terminated

4 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00422344 2010-02-26

A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

Phase 1 Completed

20 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms